These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38714931)
1. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. Zolghadriha A; Anjomshoaa A; Jamshidi MR; Taherkhani F BMC Psychiatry; 2024 May; 24(1):341. PubMed ID: 38714931 [TBL] [Abstract][Full Text] [Related]
2. Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial. Glue P; Loo C; Fam J; Lane HY; Young AH; Surman P; Nat Med; 2024 Jul; 30(7):2004-2009. PubMed ID: 38914860 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of interpersonal psychotherapy in comparison to other psychological and pharmacological interventions for reducing depressive symptoms in women diagnosed with postpartum depression in low- and middle-income countries: A systematic review. Kang HK; Bisht B; Kaur M; Alexis O; Worsley A; John D Campbell Syst Rev; 2024 Jun; 20(2):e1399. PubMed ID: 38645302 [TBL] [Abstract][Full Text] [Related]
5. The effect of the Yara smartphone application on anxiety, sleep quality, and suicidal thoughts in patients with major depressive disorder in Iran: a randomized controlled trial. Soltani Z; Parizad N; Radfar M; Alinejad V; Arzanlo M; Haghighi M BMC Psychiatry; 2024 Mar; 24(1):231. PubMed ID: 38539144 [TBL] [Abstract][Full Text] [Related]
7. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730 [TBL] [Abstract][Full Text] [Related]
8. Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo. Sampson E; Mills NT; Hori H; Cearns M; Schwarte K; Hohoff C; Oliver Schubert K; Fourrier C; Baune BT Brain Behav Immun; 2025 Jan; 123():43-56. PubMed ID: 39243988 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial. Ohtani Y; Tani H; Nomoto-Takahashi K; Yatomi T; Yonezawa K; Tomiyama S; Nagai N; Kusudo K; Honda S; Moriyama S; Nakajima S; Yamada T; Morisaki H; Iwabuchi Y; Jinzaki M; Yoshimura K; Eiro T; Tsugawa S; Ichijo S; Fujimoto Y; Miyazaki T; Takahashi T; Uchida H Psychiatry Clin Neurosci; 2024 Dec; 78(12):765-775. PubMed ID: 39210712 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments in panic disorder in adults: a network meta-analysis. Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714 [TBL] [Abstract][Full Text] [Related]
12. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
13. Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study. Palhano-Fontes F; Cavalcanti-Ribeiro P; da Costa Gonçalves KT; de Almeida VRN; Barbosa DC; de Araújo Ferreira MA; Bolcont R; De Souza LCAM; Santos NC; Lopes EITC; de Medeiros Lima NB; de Brito AJC; Falchi-Carvalho M; Arcoverde E; Araujo D; Galvão-Coelho NL J Affect Disord; 2025 Jan; 369():155-163. PubMed ID: 39341294 [TBL] [Abstract][Full Text] [Related]
14. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation. Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138 [TBL] [Abstract][Full Text] [Related]
15. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
16. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis. Curry N; Davenport R; Thomas H; Fox E; Lucas J; Evans A; Massou E; Sharma R; Shanmugaranjan S; Rourke C; Newton A; Deary A; Dallas N; Fitzpatrick-Creamer C; Podbielski JM; Wade CE; Edwards A; Benger J; Morris S; Cotton BA; Piercy J; Green L; Brohi K; Stanworth S Health Technol Assess; 2024 Nov; 28(76):1-69. PubMed ID: 39545850 [TBL] [Abstract][Full Text] [Related]
17. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
19. Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray. Samalin L; Mekaoui L; De Maricourt P; Sauvaget A; Codet MA; Gaudré-Wattinne É; Wicart C; Rothärmel M Int J Psychiatry Clin Pract; 2024 Jun; 28(2):83-93. PubMed ID: 39223855 [TBL] [Abstract][Full Text] [Related]